Pressure Bio Q3 Revenues Rise 7 Percent on PCT Business | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences saw revenues in its third quarter climb 7 percent year over year as revenues derived from its Pressure Cycling Technology grew 10 percent, the company said today.

The South Easton, Mass.-based firm said that total revenues reached $420,762 for the three months ended Sept. 30, compared to $391,616 a year ago. Revenues from PCT products, services, and other were $327,958, compared to $297,867 a year ago, while grant revenues narrowed to $92,804 from $93,749.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."